Navigation Links
Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
Date:11/3/2008

uate

-------------------------------------------------------------------------

* still on study. CR=complete response,

PR=partial response, SD=stable disease,

PD=progressive disease

The Phase I trial has two components. The first is an open-label, dose-escalating, non-randomized study of REOLYSIN(R) given intravenously to patients with paclitaxel and carboplatin every three weeks. In this portion of the trial, standard dosages of paclitaxel and carboplatin are delivered to patients with escalating dosages of REOLYSIN(R) intravenously. The second component of the trial includes the enrolment of a further nine patients at the top dose of REOLYSIN(R) in combination with a standard dosage of paclitaxel and carboplatin. Eligible patients include those who have been diagnosed with advanced or metastatic solid tumours such as melanoma, lung and ovarian that are refractory (have not responded) to standard therapy or for which no curative standard therapy exists.

The Phase II trial is a 14-patient, single arm, open-label, dose-targeted, non-randomized trial of REOLYSIN(R) given intravenously in combination with a standard dosage of paclitaxel and carboplatin. Eligible patients include those with advanced or metastatic head and neck cancers that are refractory to standard therapy or for which no curative standard therapy exists.

The poster will be available today on the Oncolytics website at http://www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 05, 2015 Research and Markets ... the "Clinical Laboratory, Molecular Diagnostics and Genomic ... 2019 - Global Version" report to their ... the area of molecular diagnostics and pharmacogenics hold ... world market that is moving out of the ...
(Date:5/5/2015)... May 05, 2015 Exotic ... distributor, announces the launch of http://www.cng.exoticautomation.com , ... with a convenient way to purchase genuine OEM ... . , The new website provides owners ... with direct access to high performance products for ...
(Date:5/4/2015)... 4, 2015 Many of us take ... certain infants with rare, inherited mutations of certain ... of their impaired immune responses. Now, ... an important role for calcium signaling in immune ... the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)...  Tikcro Technologies Ltd. (OTCQB: TIKRF) announced today that ... for the fiscal year ended December 31, 2014 with ... report on Form 20-F contains information regarding its biotechnology ... of cancer immune checkpoints. This project aims to develop ... binding in targeting certain identified immune checkpoints. The filing ...
Breaking Biology Technology:Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Exotic Automation & Supply Launches Ecommerce Website 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2
... exclusive, distribution agreement with AZPA International Inc. for Australia and New ... ... LAVAL, QC, Dec. 19 /PRNewswire-FirstCall/ - Neptune Technologies &,Bioressources Inc. ("Neptune") ... an exclusive distribution agreement with,AZPA International Inc. ("AZPA International") for Australia ...
... collaborators, LineaGen is leveraging new funding round, Utah Population ... platform for commercializing first-in-class molecular diagnostic ... ... Inc.,( http://www.LineaGen.com ), a biomarker discovery company created to,discover and commercialize ...
... the Announcement of a Tracking Program for,Cloned Livestock, ... a,statement by International Dairy Foods Association President and ... a new national registry to track cloned,livestock as ... over food,products from cloned animals. However, we strongly ...
Cached Biology Technology:Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 2Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 3LineaGen Inc. Launches With Close of $5.8 Million Series A Funding Round 2LineaGen Inc. Launches With Close of $5.8 Million Series A Funding Round 3LineaGen Inc. Launches With Close of $5.8 Million Series A Funding Round 4Statement of International Dairy Foods Association President and CEO Connie Tipton 2
(Date:4/20/2015)... The announcement comes as demand for fire ... Ireland,s foremost records management company, has ... an impressive track record of clients within the first 12 ... management sector in Dubai . As a ... employ a further eight staff members at its Irish headquarters. ...
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... in Hong Kong this year. So far, 466 children were infected ... Streptococcus pyogenes, a gram-positive pathogen that can be transmitted via ... Hong Kong Center for Disease Control (HK CDC), Hong Kong University ... the S. pyogenes strain that was isolated from a ...
... Va. recently found a way to improve electricity generating ... less expensive. Specifically, they discovered a way to speed ... which are necessary for fuel cells to operate. ... membrane, or PEM, commonly used in fuel cells and ...
... and the USDA Agricultural Research Service have developed a new ... boniato, or tropical sweet potato, Liberty has a dark red ... Boniato potatoes originated in the tropical Americas and are grown ... served fried, mashed or in soup. "We developed Liberty ...
Cached Biology News:Hong Kong University leads the genomics research of scarlet fever pathogen 2Stretching old material yields new results for energy- and environment-related devices 2
Fast, sensitive quantitation of Mouse IgM concentration....
Detect and measure levels of mouse IgG3 antibody isotypes quickly and easily....
Request Info...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Biology Products: